Out“FOX”ing cancer: the implications of FOXC2 as a putative predictive biomarker for cancer immunotherapy - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FOXC2: Evaluating Its Potential as a Predictive Biomarker for Cancer Immunotherapy

  • By

  • Kristian M. Hargadon

  • June 30, 2026

Share

Original Source(s)

Out“FOX”ing cancer: the implications of FOXC2 as a putative predictive biomarker for cancer immunotherapy

  • by Kristian M. Hargadon

  • June 30, 2026

Related Content

National Cancer Institute–Supported Obesity and Cancer Research, 2015-2022

Moving Cancer Survivorship Into Routine Care—Why Are We Still Not Ready for Change?

Correction: Lipid profile-based prognostic nomograms for obstructive colorectal cancer: multi-cohort development and validation